Academic Journals Database
Disseminating quality controlled scientific knowledge

Patients with a future diagnosis of diabetes have higher drug use and costs: an analysis of community pharmacy data

Author(s): Sandra De Coster | Gert Laekeman | Jan Lenie | Véronique Hayen | Steven Simoens

Journal: Endocrinology Studies
ISSN 2038-9515

Volume: 1;
Issue: 1;
Start page: e6;
Date: 2011;
Original page

This study explores whether patients with Type 2 diabetes mellitus have higher drug use as compared to patients without diabetes over a time period prior to and after diagnosis of diabetes. A case-control study compared drug use of patients with a future diagnosis of diabetes (cases) with patients without a diagnosis (controls) based on community pharmacy records. Cases had used oral hypoglycaemic drugs during 2006. A repeated measures analysis calculated the mean number of packages and costs of drugs in cases during the two years prior to diagnosis and the first year following diagnosis and in control patients during three years. Volume of drug use was expressed as the number of packages consumed by a patient. Drug costs were based on the public price. Our dataset covered 2,697 patients (899 cases and 1,798 control patients). The mean annual number of packages and costs of drugs increased over time for cases and control patients (p
RPA Switzerland

RPA Switzerland

Robotic process automation


Tango Jona
Tangokurs Rapperswil-Jona